These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 26859552)

  • 1. Metabolic effects of bile acid sequestration: impact on cardiovascular risk factors.
    Spinelli V; Chávez-Talavera O; Tailleux A; Staels B
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):138-44. PubMed ID: 26859552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile-acid-activated receptors: targeting TGR5 and farnesoid-X-receptor in lipid and glucose disorders.
    Fiorucci S; Mencarelli A; Palladino G; Cipriani S
    Trends Pharmacol Sci; 2009 Nov; 30(11):570-80. PubMed ID: 19758712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion.
    Sonne DP; Hansen M; Knop FK
    Eur J Endocrinol; 2014 Aug; 171(2):R47-65. PubMed ID: 24760535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes.
    González-Regueiro JA; Moreno-Castañeda L; Uribe M; Chávez-Tapia NC
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):16-21. PubMed ID: 29118282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease.
    Porez G; Prawitt J; Gross B; Staels B
    J Lipid Res; 2012 Sep; 53(9):1723-37. PubMed ID: 22550135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic Bile Acid Reuptake in the Rat Depends on Bile Acid Conjugation but Not on Agonistic Properties towards FXR and TGR5.
    Trammell SAJ; Svenningsen JS; Holst JJ; Gillum MP; Kuhre RE
    Molecules; 2020 May; 25(10):. PubMed ID: 32443832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-lowering effects of intestinal bile acid sequestration through enhancement of splanchnic glucose utilization.
    Prawitt J; Caron S; Staels B
    Trends Endocrinol Metab; 2014 May; 25(5):235-44. PubMed ID: 24731596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease.
    Chávez-Talavera O; Tailleux A; Lefebvre P; Staels B
    Gastroenterology; 2017 May; 152(7):1679-1694.e3. PubMed ID: 28214524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation.
    Chiang JY; Pathak P; Liu H; Donepudi A; Ferrell J; Boehme S
    Dig Dis; 2017; 35(3):241-245. PubMed ID: 28249273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism.
    Pathak P; Xie C; Nichols RG; Ferrell JM; Boehme S; Krausz KW; Patterson AD; Gonzalez FJ; Chiang JYL
    Hepatology; 2018 Oct; 68(4):1574-1588. PubMed ID: 29486523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights in the multiple roles of bile acids and their signaling pathways in metabolic control.
    de Boer JF; Bloks VW; Verkade E; Heiner-Fokkema MR; Kuipers F
    Curr Opin Lipidol; 2018 Jun; 29(3):194-202. PubMed ID: 29553998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acids as metabolic regulators.
    Li T; Chiang JY
    Curr Opin Gastroenterol; 2015 Mar; 31(2):159-65. PubMed ID: 25584736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bile acid sequestrants: glucose-lowering mechanisms.
    Prawitt J; Staels B
    Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S3-8. PubMed ID: 20977365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal bile acid receptors are key regulators of glucose homeostasis.
    Trabelsi MS; Lestavel S; Staels B; Collet X
    Proc Nutr Soc; 2017 Aug; 76(3):192-202. PubMed ID: 27846919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bile acid treatment and FXR agonism lower postprandial lipemia in mice.
    Farr S; Stankovic B; Hoffman S; Masoudpoor H; Baker C; Taher J; Dean AE; Anakk S; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2020 Apr; 318(4):G682-G693. PubMed ID: 32003602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acids in glucose metabolism in health and disease.
    Shapiro H; Kolodziejczyk AA; Halstuch D; Elinav E
    J Exp Med; 2018 Feb; 215(2):383-396. PubMed ID: 29339445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond intestinal soap--bile acids in metabolic control.
    Kuipers F; Bloks VW; Groen AK
    Nat Rev Endocrinol; 2014 Aug; 10(8):488-98. PubMed ID: 24821328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acids and their effects on diabetes.
    Rajani C; Jia W
    Front Med; 2018 Dec; 12(6):608-623. PubMed ID: 30306382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes.
    Hansen M; Sonne DP; Knop FK
    Curr Diab Rep; 2014; 14(5):482. PubMed ID: 24623198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.